Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.34 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.34 |
| ▸ | RELA | Q04206 | 1/20 | 0.34 |
| ▸ | PRKCA | P17252 | 5/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 2/20 | 0.32 |
| ▸ | TYR | P14679 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | CCR5 | P51681 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11560691 | 0.98 | TSHR (0.39) | TSHRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL27820083 | 0.74 | TSHR (0.30) | TSHRNFKB1NFKB2RELA | |
| SCHEMBL27520703 | 0.70 | CCR5 (0.35) | TSHRNFKB1NFKB2RELACCR5 | |
| SCHEMBL15618384 | 0.67 | TSHR (0.44) | TSHRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL1797486 | 0.67 | TSHR (0.44) | TSHRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL353470 | 0.67 | TSHR (0.44) | TSHRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL21300 | 0.67 | TSHR (0.44) | TSHRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL14915686 | 0.67 | TSHR (0.44) | TSHRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL15618662 | 0.67 | TSHR (0.44) | TSHRNFKB1NFKB2RELAPRKCA | |
| SCHEMBL5606129 | 0.67 | TSHR (0.44) | TSHRNFKB1NFKB2RELAPRKCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2732312-B2 | — | — | 1998-03-30 | — | — | JP | claimed |
| EP-0766553-A1 | INTRAOCULAR IRRIGATING SOLUTION CONTAINING AGENT FOR CONTROLLING IOP | ALCON LABORATORIES, INC. (US) | 1997-04-09 | — | — | EP | claimed |
| US-5605922-A | VISION DISORDERS; SIDE EFFECT REDUCTION | ALCON LABORATORIES, INC. (US) | 1997-02-25 | — | — | US | claimed |
| US-5523316-A | COMPRISES AN ANTIOXIDANT/FREE RADICAL SCAVENGER, ELECTROLYTES, CELLULAR ENERGY SOURCE, BICARBONATE AND A BUFFER | ALCON LABORATORIES, INC. (US) | 1996-06-04 | — | — | US | claimed |
| WO-1996000055-A1 | INTRAOCULAR IRRIGATING SOLUTION CONTAINING AGENT FOR CONTROLLING IOP | ALCON LABORATORIES, INC. (US) | 1996-01-04 | — | — | WO | claimed |
| EP-0365662-B1 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS | ALCON LAB INC (US) | 1994-03-09 | — | — | EP | claimed |
| EP-0365662-A4 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS | — | 1990-10-24 | — | — | EP | claimed |
| EP-0365662-A1 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS. | ALCON LAB INC (US) | 1990-05-02 | — | — | EP | claimed |
| WO-1989010126-A1 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS | ALCON LABORATORIES, INC. (US) | 1989-11-02 | — | — | WO | claimed |
| US-5811443-A | SIDE EFFECT REDUCTION | ALCON LABORATORIES, INC. (US) | 1998-09-22 | — | — | US | disclosed |
| EP-0664707-B1 | COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA | ALCON LAB INC (US) | 1997-06-04 | — | — | EP | disclosed |
| EP-0766553-A1 | INTRAOCULAR IRRIGATING SOLUTION CONTAINING AGENT FOR CONTROLLING IOP | ALCON LABORATORIES, INC. (US) | 1997-04-09 | — | — | EP | disclosed |
| US-5605922-A | VISION DISORDERS; SIDE EFFECT REDUCTION | ALCON LABORATORIES, INC. (US) | 1997-02-25 | — | — | US | disclosed |
| US-5523316-A | COMPRISES AN ANTIOXIDANT/FREE RADICAL SCAVENGER, ELECTROLYTES, CELLULAR ENERGY SOURCE, BICARBONATE AND A BUFFER | ALCON LABORATORIES, INC. (US) | 1996-06-04 | — | — | US | disclosed |
| EP-0664707-A1 | COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA. | ALCON LAB INC (US) | 1995-08-02 | — | — | EP | disclosed |
| WO-1994008585-A1 | COMBINATIONS OF PROSTAGLANDINS AND CLONIDINE DERIVATIVES FOR THE TREATMENT OF GLAUCOMA | ALCON LABORATORIES, INC. (US) | 1994-04-28 | — | — | WO | disclosed |
| EP-0365662-B1 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS | ALCON LAB INC (US) | 1994-03-09 | — | — | EP | disclosed |
| EP-0365662-A4 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS | — | 1990-10-24 | — | — | EP | disclosed |
| EP-0365662-A1 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS. | ALCON LAB INC (US) | 1990-05-02 | — | — | EP | disclosed |
| WO-1989010126-A1 | ANTIGLAUCOMA COMPOSITIONS CONTAINING COMBINATIONS OF ALPHA-2 AGONISTS AND BETA-BLOCKERS | ALCON LABORATORIES, INC. (US) | 1989-11-02 | — | — | WO | disclosed |